Smith & Nephew to redeem $350M notes on October 5

The scheduled payment combines a 100.245% redemption price with $2.15 of accrued interest per $1,000 principal amount.

Rhea-AI Filing Summary

Smith & Nephew plc will redeem the entire outstanding principal amount of its $350,000,000 5.150% Notes due 2027 on October 5, 2026. The redemption price is 100.245%, or $1,002.45 per $1,000 principal amount, plus $2.15 per $1,000 in accrued and unpaid interest, for a total payment of $1,004.60 per $1,000.

From and after the redemption date, the notes will cease to bear interest and will be deemed no longer outstanding under the Indenture. Holders of notes called for redemption will retain the right to receive the redemption payment.

Key Figures

Principal amount to be redeemed: $350,000,000 Interest rate: 5.150% Redemption date: October 5, 2026 +4 more

7 metrics

Principal amount to be redeemed $350,000,000 Entire outstanding principal amount of the 5.150% Notes due 2027

Interest rate 5.150% Notes due 2027

Redemption date October 5, 2026 Date the outstanding notes are to be redeemed

Redemption price 100.245% Price for each $1,000 principal amount

Redemption price per $1,000 $1,002.45 Per $1,000 principal amount

Accrued and unpaid interest $2.15 per $1,000 Interest through, but excluding, the redemption date

Redemption payment $1,004.60 per $1,000 Amount payable to holders on the redemption date

Key Terms

Indenture, Redemption Price, Accrued and unpaid interest, principal amount

4 terms

Indenture financial

"terms of the Indenture dated October 14, 2020"

An indenture is a legal agreement between a company that borrows money by issuing bonds and the people who buy those bonds. It explains the rules the company must follow, like paying back the money and keeping certain financial promises. This document helps both sides understand their rights and responsibilities.

Redemption Price financial

"the “Redemption Price”"

The redemption price is the amount of money a person receives when they sell or redeem a bond or investment before it matures. It’s important because it determines how much you get back and can affect your overall profit or loss on the investment. Think of it like the price you get when returning a gift card early—it's the value you receive at that time.

Accrued and unpaid interest financial

"Accrued and unpaid interest on the principal amount"

Accrued and unpaid interest is the interest that has built up on a loan or debt but hasn't been paid yet. It's like owing your friend money for a favor over time—you're expected to pay it later, even though you haven't paid it yet. This matters because it shows how much you owe beyond the original amount borrowed.

principal amount financial

"$1,000 principal amount of the Securities"

The principal amount is the original sum of money that is borrowed, lent, or invested before any interest, fees, or returns are added. It matters to investors because interest charges, scheduled repayments, and total return are calculated from that base amount — think of it as the price tag on which future costs or gains are built. Knowing the principal helps you compare deals and predict cash flows and risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much will SNN pay for each $1,000 of notes redeemed?

The scheduled redemption payment is $1,004.60 per $1,000 principal amount, comprising a redemption price of $1,002.45 and $2.15 in accrued and unpaid interest.

What happens to SNN's 5.150% Notes after October 5, 2026?

From and after the redemption date, the notes will cease to bear interest and be deemed no longer outstanding under the Indenture. Holders of notes called for redemption will retain the right to receive the redemption payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 06:07 AM Accepted by SEC EDGAR 10/01/2026 - 06:05 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 under the

Securities Exchange Act of 1934

October 01, 2026

Commission File Number 001-14978

SMITH & NEPHEW plc

(Registrant’s name)

Building 5, Croxley Park, Hatters Lane

Watford, England, WD18 8YE

 (Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ✔         Form 40-F __

Redemption of $350,000,000 5.150% Notes due 2027

Smith & Nephew plc

Notice of Redemption Price

 $350,000,000 5.150% Notes due 2027 (CUSIP: 83192PAC2, ISIN: US83192PAC23) (the “Securities”)

October 1, 2026. Smith & Nephew plc (the “Issuer”) announces that it has issued a notice of redemption price following the notice of redemption dated September 18, 2026 related to the redemption of the entire outstanding principal amount of the Securities pursuant to the terms of the Indenture dated October 14, 2020 (the “Indenture”) governing the Securities between the Issuer and The Bank of New York Mellon, London Branch (the “Trustee”).

The outstanding Securities will be redeemed on October 5, 2026 (the “Redemption Date”) at a redemption price equal to 100.245% which is $1002.45 per $1,000 principal amount of the Securities (the “Redemption Price”).  Accrued and unpaid interest on the principal amount of the Securities to be redeemed up to (but excluding) the Redemption Date is $2.15 per $1,000 principal amount of the Securities.  Accordingly, the amount to be paid to holders of the Securities on the Redemption Date shall equal $1004.60 per $1,000 principal amount of the Securities (the “Redemption Payment”).

From and after the Redemption Date, the Securities will cease to bear interest, and the only remaining right of holders of the Securities called for redemption will be to receive payment of the Redemption Payment.

For all purposes of the Indenture, the Securities called for redemption will be deemed to be no longer outstanding from and after the Redemption Date.

For further information in relation to the redemption of the Securities, please contact:

Group Treasury:

Adam Richford

Group Treasurer

Telephone: +44 01923 477 100

Smith+Nephew Forward-looking Statements

This announcement contains certain “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organization to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; effects of AI use and deployment; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F for the year ended December 31, 2025 and interim financial statements on Form 6-K for the six months period ended June 27, 2026, which are available on the SEC’s website at www. sec.gov and the Offer to Purchase, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. The Company can give no assurance that any goal or plan set forth in the Company’s forward-looking statements will be achieved and readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Smith & Nephew plc
		(Registrant)
Date: October 01, 2026	By:	/s/ Helen Barraclough
		Helen Barraclough
		Company Secretary